By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
A medical imaging technology called single-photon emission computed tomography (SPECT) is used to provide finely detailed images of the organs and tissues inside the body.
It operates by detecting the radiation that is given off by a radioactive tracer put into the patient’s bloodstream and accumulates in the target organ or tissue.
A gamma camera, a specialized camera that detects the radiation emitted by the tracer, is part of a big piece of equipment called a SPECT scanner.
Gamma imaging uses a rotating camera to take several photos of the patient from various perspectives. A 3D image of the organ or tissue under study is produced by combining these photographs on a computer.
Nuclear medicine frequently employs SPECT to identify and track a wide range of illnesses, including neurological problems, cancer, and heart disease.
In the case of heart disease, for instance, SPECT can be used to assess blood flow to the heart and spot areas of decreased blood flow that might be caused by blocked or congested arteries. SPECT can be used to detect the spread of cancer to other body parts in cases of cancer.
Although a small amount of radiation from the tracer must be exposed, SPECT is regarded as a secure and non-invasive imaging technique. The radiation exposure is typically regarded as safe and is comparable to other imaging methods like X-rays and CT scans.
The Global Single-Photon Emission Computed Tomography (SPECT) Scanner Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Symbia Pro.specta, a single photon emission computed tomography/computed tomography (SPECT/CT) system combining cutting-edge SPECT and CT imaging technologies, is unveiled by Siemens Healthineers.
It has the CE mark and FDA clearance. A low-dose CT with up to 64 slices for stunning detail is one of the capabilities. Another is automatic SPECT motion correction for improved picture clarity.
A workflow that is both straightforward and automated is another. An all-purpose system, Symbia Pro.specta can be tailored to support a variety of clinical tests, patient types, and departmental settings.
MyExam Companion, the centrepiece of Symbia Pro.specta, features an intuitive user interface and does away with the conventional manual and user-dependent SPECT/CT imaging approach.
From system and patient setup to picture collecting and reconstruction to evaluation and postprocessing, myExam Companion offers automated tools to lead the user through each step of the exam’s decision-making process.
No matter the patient, process, or user experience level, this enables departments to obtain consistent results more quickly and easily.
Data-driven patient motion correction, which automatically corrects for patient movement in a SPECT test with the press of a button and improves image quality without adding complexity, is another significant innovation that is included as standard.
Additionally, there is an option for data-driven respiratory motion correction for cardiac examinations.
SPECT/CT and Single Imaging Gamma Cameras are the two products offered in the single-photon emission computed tomography (SPECT) market.
In this market, values are determined at the “factory gate,” or the price at which items are sold by producers, whether they sell them directly to consumers or to downstream producers, wholesalers, distributors, or retailers.
Single-photon emission computed tomography (SPECT) is a medical imaging method that creates 3D images of inside organs and tissues using radioactive tracers and gamma rays.
A gamma camera can detect the tracer because it emits gamma rays, which enables non-invasive and thorough imaging of a patient’s interior anatomy.
Single-photon emission computed tomography (SPECT) systems can be divided into two categories: standalone and hybrid SPECT systems.
A medical imaging gadget known as a hybrid SPECT system combines functional and anatomical data from SPECT with CT or MRI to produce more precise diagnosis. Tc-99m, Ra-223, Ga-67, I-123, and other radioisotopes are some of the radioisotopes used in SPECT systems.
These systems are used by hospitals, diagnostic facilities, and other end users in a range of applications including oncology, cardiology, and neurology.
The market for single-photon emission computed tomography (SPECT) is anticipated to develop in the future due to the rising incidence of cancer cases.Because of an ageing population, bad lifestyle choices, and environmental factors, there has been an increase in cancer diagnoses.
In the market for single-photon emission computed tomography (SPECT), technological developments are a crucial trend that is becoming more well-liked.
Businesses involved in the single-photon emission computed tomography (SPECT) industry are implementing cutting-edge innovations including high-resolution imaging to maintain their market share.
Researchers can increase the use of SPECT systems by extending the number of ailments and disorders that may be detected and tracked using this technology.
As a result of the widened range of potential uses, SPECT imaging may become more popular, driving up demand and propelling market expansion. R&D activities result in technological developments in SPECT imaging systems, which include enhancements in image quality, resolution, sensitivity, and acquisition speed.
The primary advantage of SPECT/CT is the improved localization and diagnostic accuracy for a variety of applications. Patients and doctors stand to gain more from the seamless collection of functional and anatomical imaging data.
Picture attenuation correction is improved by SPECT/CT because it decreases logistical delays. An advantage is having quick access to additional image data.
Demand for better diagnostic techniques is expanding at the same time that awareness of early and prompt diagnosis grows. This need in the healthcare industry is seen as opening up a wide range of commercial potential by increasing the installation and utilisation of SPECT systems
North America
The North American market, particularly the USA, will be one of the prime markets for (Single-Photon Emission Computed Tomography (SPECT) Scanner) due to the nature of industrial automation in the region, high consumer spending compared to other regions, and the growth of various industries, mainly AI, along with constant technological advancements. The GDP of the USA is one of the largest in the world, and it is home to various industries such as Pharmaceuticals, Aerospace, and Technology. The average consumer spending in the region was $72K in 2023, and this is set to increase over the forecast period. Industries are focused on industrial automation and increasing efficiency in the region. This will be facilitated by the growth in IoT and AI across the board. Due to tensions in geopolitics, much manufacturing is set to shift towards the USA and Mexico, away from China. This shift will include industries such as semiconductors and automotive.
Europe
The European market, particularly Western Europe, is another prime market for (Single-Photon Emission Computed Tomography (SPECT) Scanner) due to the strong economic conditions in the region, bolstered by robust systems that support sustained growth. This includes research and development of new technologies, constant innovation, and developments across various industries that promote regional growth. Investments are being made to develop and improve existing infrastructure, enabling various industries to thrive. In Western Europe, the margins for (Single-Photon Emission Computed Tomography (SPECT) Scanner) are higher than in other parts of the world due to regional supply and demand dynamics. Average consumer spending in the region was lower than in the USA in 2023, but it is expected to increase over the forecast period.
Eastern Europe is anticipated to experience a higher growth rate compared to Western Europe, as significant shifts in manufacturing and development are taking place in countries like Poland and Hungary. However, the Russia-Ukraine war is currently disrupting growth in this region, with the lack of an immediate resolution negatively impacting growth and creating instability in neighboring areas. Despite these challenges, technological hubs are emerging in Eastern Europe, driven by lower labor costs and a strong supply of technological capabilities compared to Western Europe.
There is a significant boom in manufacturing within Europe, especially in the semiconductor industry, which is expected to influence other industries. Major improvements in the development of sectors such as renewable energy, industrial automation, automotive manufacturing, battery manufacturing and recycling, and AI are poised to promote the growth of (Single-Photon Emission Computed Tomography (SPECT) Scanner) in the region.
Asia
Asia will continue to be the global manufacturing hub for (Single-Photon Emission Computed Tomography (SPECT) Scanner Market) over the forecast period with China dominating the manufacturing. However, there will be a shift in manufacturing towards other Asian countries such as India and Vietnam. The technological developments will come from China, Japan, South Korea, and India for the region. There is a trend to improve the efficiency as well as the quality of goods and services to keep up with the standards that are present internationally as well as win the fight in terms of pricing in this region. The demand in this region will also be driven by infrastructural developments that will take place over the forecast period to improve the output for various industries in different countries.
There will be higher growth in the Middle East as investments fall into place to improve their standing in various industries away from petroleum. Plans such as Saudi Arabia Vision 2030, Qatar Vision 2030, and Abu Dhabi 2030 will cause developments across multiple industries in the region. There is a focus on improving the manufacturing sector as well as the knowledge-based services to cater to the needs of the region and the rest of the world. Due to the shifting nature of fossil fuels, the region will be ready with multiple other revenue sources by the time comes, though fossil fuels are not going away any time soon.
Africa
Africa is expected to see the largest growth in (Single-Photon Emission Computed Tomography (SPECT) Scanner Market) over the forecast period, as the region prepares to advance across multiple fronts. This growth aligns with the surge of investments targeting key sectors such as agriculture, mining, financial services, manufacturing, logistics, automotive, and healthcare. These investments are poised to stimulate overall regional growth, creating ripple effects across other industries as consumer spending increases, access to products improves, and product offerings expand. This development is supported by both established companies and startups in the region, with assistance from various charitable organizations. Additionally, the presence of a young workforce will address various existing regional challenges. There has been an improvement in political stability, which has attracted and will continue to attract more foreign investments. Initiatives like the African Continental Free Trade Area (AfCFTA) are set to facilitate the easier movement of goods and services within the region, further enhancing the economic landscape.
RoW
Latin America and the Oceania region will showcase growth over the forecast period in (Single-Photon Emission Computed Tomography (SPECT) Scanner Market). In Latin America, the focus in the forecast period will be to improve their manufacturing capabilities which is supported by foreign investments in the region. This will be across industries mainly automotive and medical devices. There will also be an increase in mining activities over the forecast period in this region. The area is ripe for industrial automation to enable improvements in manufacturing across different industries and efficiency improvements. This will lead to growth of other industries in the region.
USA – $210 billion is allocated to federal R&D with main focus on health research, clean energy, semiconductor manufacturing, sustainable textiles, clean energy, and advanced manufacturing. Investments by private players are mainly focused on technological development including 5G infrastructure and AI in the region.
Europe – EIC is investing €1 billion to innovative companies in sectors like AI, biotechnology, and semiconductors. There is also a focus on developing the ecosystem in the continent as well as improving the infrastructure for developing industries such as electric vehicles and sustainable materials. Private players are targeting data centers, AI, battery plants, and high end technological R&D investments.
Asia – There are investments to tackle a range of scientific and technological advancements in this region mainly coming in from China, India, South Korea, and Japan. This will include artificial intelligence, 5G, cloud computing, pharmaceutical, local manufacturing, and financial technologies. Many countries are aiming to be digital hubs including Saudi Arabia.
Africa – Investments in the region are focused on improving the technological capabilities in the region along with socio-economic development and growth. Private participants of investments in this region is venture capital dominated who are targeting the various growth elements of the region as social stability improves. The major industries are fintech, easier lending, and manufacturing.
Latin America – The focus in the region is for fintech, e-commerce, and mobility sectors. There are also investments in improving manufacturing in the region. Local investments is focused on improving the healthcare, and transportation infrastructure in the region. The region is attracting foreign investments to improve their ability to utilize the natural resources present in the region.
Rest of the World – The investments in this region are focused on clean energy, green metals, and sustainable materials. Funds in Australia are focused on solar energy and battery technologies, along with high end futuristic areas such as quantum computing. The main countries of private investment in ROW will be Australia, Canada, and New Zealand.
